UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 10, 2023
Accession Number:
0001193125-23-206895
Submission Type:
POS AM
CIK:
0001645569
Company Name:
DICE Therapeutics, Inc.
File Number:
333-267702